We recently compiled a list of the 13 Best Dividend Stocks to Buy Under $50. In this article, we are going to take a look at ...

We recently published a list of the 8 Best Dividend Leaders to Buy According to Wall Street Analysts. In this article, we are ...

Pfizer trades at a 21.7% discount to peers on a 1-yr forward P/E basis, which is a point for the bullish arguments. Find out ...

Pfizer's oncology promises are several years from being actualized. Read why investors shouldn't assume that a sustained ...

Despite today’s strength, Pfizer shares are trading deep in a long-term bear market trend. The stock crossed into bearish ...

In the latest trading session, Pfizer (PFE) closed at $26.56, marking a -0.67% move from the previous day. The stock's performance was behind the S&P 500's daily loss of 0.04%. Elsewhere ...

As of the latest trading close, PFE, a Healthcare sector stock, is trading -18.90% below its 52-week high but remains 4.49% above its 52-week low. The Average True Range (ATR) (14 days) of 0.55 ...

Dividend-paying stocks provide investors with consistent income in turbulent markets, especially as payouts grow over time.

Pfizer Inc. (NYSE:PFE) will conduct an investor call on Tuesday to provide full-year 2025 financial guidance. Ahead of the ...

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other dividend stocks. AI stocks are stealing the spotlight today as the appetite for these services ...